Person

Michael J. Rider

Global General Counsel, ResMed

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$580K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

  • RMD
    ResMed
    Global General Counsel
    since Jul 2023

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Oct 23, 2026RMDSale400$255.00$102K
Feb 4, 2026RMDSale50$260.00$13K
Jan 2, 2026RMDSale50$241.75$12K
Dec 1, 2025RMDSale50$244.16$12K
Oct 1, 2025RMDSale100$274.36$27K
Aug 1, 2025RMDSale50$281.90$14K
Jul 1, 2025RMDSale66$256.99$17K
Jun 2, 2025RMDSale41$243.78$10K
Apr 1, 2025RMDSale64$222.86$14K
Mar 3, 2025RMDSale64$234.10$15K
Feb 3, 2025RMDSale64$242.42$16K
Jan 2, 2025RMDSale75$230.99$17K
Dec 2, 2024RMDSale74$248.91$18K
Nov 1, 2024RMDSale69$242.00$17K
Aug 20, 2024RMDSale882$231.00$204K
Mar 4, 2024RMDSale81$180.00$15K
Mar 1, 2024RMDSale200$173.25$35K
Nov 1, 2023RMDSale25$143.42$4K
Oct 2, 2023RMDSale25$145.92$4K
Sep 1, 2023RMDSale25$161.15$4K
Aug 1, 2023RMDSale25$224.12$6K
Jul 3, 2023RMDSale25$217.21$5K

SEC reporting-owner ID (CIK) 1982205 · all filings on EDGAR